Viatris (VTRS) announced FDA approval of RYZUMVI (phentolamine ophthalmic solution 0.75%) for presbyopia in adults. The drug was previously approved for pharmacologically-induced mydriasis. Viatris is exploring a US partner to commercialize the expanded indication.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.
